Moderna and Merck Shares Surge After Melanoma Vaccine Trial Success
Moderna (MRNA) and Merck (MRK) shares surged after a large trial demonstrated their investigational mRNA melanoma vaccine reduced recurrence, lifting the oncology…
Moderna (MRNA) and Merck (MRK) shares surged after a large trial demonstrated their investigational mRNA melanoma vaccine reduced recurrence, lifting the oncology…
US kindergarten vaccine rates fell again in 2025-26, with exemptions hitting a record high, signaling rising vaccine hesitancy that threatens herd immunity…
Merck and Hashgraph Group launched a Hedera-based product passport to comply with new EU sustainability and supply-chain rules, reinforcing blockchain's role in…